Patents Assigned to The University
  • Patent number: 9006473
    Abstract: Described herein are nitrated lipids and methods of making and using the nitrated lipids.
    Type: Grant
    Filed: October 8, 2012
    Date of Patent: April 14, 2015
    Assignees: The UAB Research Foundation, The State of Oregon Acting By and Through the State Board of Higher Education on Behalf of The University of Oregon, University College Cardiff Consultants Limited, Morehouse School of Medicine, Inc.
    Inventors: Bruce A. Freeman, Francisco Schopfer, Valerie O'Donnell, Paul Baker, Yuqing E. Chen, Bruce Branchaud
  • Patent number: 9005962
    Abstract: The present invention relates to the generation of anterior definitive endoderm (ADE) cells from embryonic stem cells and the differentiation of such cells to, for example, pancreatic or liver cells. The invention also relates to cell lines, cell culture methods, cells markers and the like and their potential uses in a variety of applications.
    Type: Grant
    Filed: August 25, 2008
    Date of Patent: April 14, 2015
    Assignee: The University Court of the University of Edinburgh
    Inventors: Gillian Mary Morrison, Joshua Mark Brickman, Ifigenia Oikonomopoulou
  • Patent number: 9006648
    Abstract: Microchips which are particularly suitable for use with a mass spectrometer include a microchip body with at least one fluid channel formed into the microchip body and at least two flat monolithic closely spaced integrated ESI (electrospray ionization) emitters defined by shaped projections formed to extend from one side of the microchip body, a respective one being in fluid communication with a fluid channel. Related systems and methods are also described.
    Type: Grant
    Filed: March 5, 2012
    Date of Patent: April 14, 2015
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: John Michael Ramsey, Andrew Chambers
  • Patent number: 9006198
    Abstract: Disclosed herein are antisense compounds and methods for selectively reducing expression of an allelic variant of a huntingtin gene containing a single nucleotide polymorphism (SNP). Such methods, compounds, and composition are useful to treat, prevent, or ameliorate Huntington's Disease (HD).
    Type: Grant
    Filed: February 8, 2011
    Date of Patent: April 14, 2015
    Assignees: Isis Pharmaceuticals, Inc., The University of British Columbia
    Inventors: C. Frank Bennett, Michael Hayden, Susan M. Freier, Sarah Greenlee, Jeffrey Carroll, Simon Warby, Eric E. Swayze
  • Patent number: 9006016
    Abstract: The present invention provides a method and apparatus for fabricating piezoresistive polysilicon on a substrate by low-temperature metal induced crystallization by: (1) providing the substrate having a passivation layer; (2) performing, at or near room temperature in a chamber without breaking a vacuum or near-vacuum within the chamber, the steps of: (a) creating a metal layer on the passivation layer, and (b) creating an amorphous silicon layer on the metal layer, wherein the metal layer and the amorphous silicon layer have approximately the same thickness; (3) annealing the substrate, the passivation layer, the metal layer and the amorphous silicon layer at a temperature equal to or less than 600° C. and a period of time equal to or less than three hours to form a doped polysilicon layer below a residual metal layer; and (4) removing the residual metal layer to expose the doped polysilicon layer.
    Type: Grant
    Filed: June 24, 2013
    Date of Patent: April 14, 2015
    Assignee: Board of Regents, The University of Texas System
    Inventors: Zeynep Celik-Butler, Suraj K. Patil, Donald Philip Butler
  • Patent number: 9008471
    Abstract: Circuits and circuit elements adapted to function at optical or infrared frequencies are made from plasmonic and/or nonplasmonic particles disposed on a substrate, where the plasmonic and nonplasmonic particles have respective dimensions substantially smaller than a wavelength of an applied optical or infrared signal. Such particles are deposited on a substrate in a variety of shapes and sizes from a variety of plasmonic and/or nonplasmonic materials so as to form resistors, capacitors, inductors and circuits made from combinations of these elements.
    Type: Grant
    Filed: June 20, 2005
    Date of Patent: April 14, 2015
    Assignee: The Trustees Of The University Of Pennsylvania
    Inventors: Nader Engheta, Alessandro Salandrino, Andrea Alu
  • Patent number: 9006399
    Abstract: Human antibodies, preferably recombinant human antibodies, both humanized and chimeric, which specifically bind to human OX40 are disclosed. Preferred antibodies have high affinity for OX40 receptor and activate the receptor in vitro and in vivo. The antibody can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, are useful for modulating receptor activity, e.g., in a human subject suffering from a disorder in which OX40 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies are provided, and methods of synthesizing the recombinant human antibodies, are also provided.
    Type: Grant
    Filed: August 23, 2011
    Date of Patent: April 14, 2015
    Assignee: Board of Regents, The University of Texas System
    Inventors: Yong-Jun Liu, Kui Shin Voo, Laura Bover, Naoya Tsurushita, J. Yun Tso, Shankar Kumar
  • Publication number: 20150100599
    Abstract: Recommendation systems are widely used in Internet applications. In current recommendation systems, users only play a passive role and have limited control over the recommendation generation process. As a result, there is often considerable mismatch between the recommendations made by these systems and the actual user interests, which are fine-grained and constantly evolving. With a user-powered distributed recommendation architecture, individual users can flexibly define fine-grained communities of interest in a declarative fashion and obtain recommendations accurately tailored to their interests by aggregating opinions of users in such communities. By combining a progressive sampling technique with data perturbation methods, the recommendation system is both scalable and privacy-preserving.
    Type: Application
    Filed: December 11, 2014
    Publication date: April 9, 2015
    Applicants: AT&T Intellectual Property I, L.P., Board of Regents, The University of Texas System
    Inventors: Kadangode K. Ramakrishnan, Divesh Srivastava, Tae Won Cho, Yin Zhang
  • Publication number: 20150098641
    Abstract: Provided herein is a method for quantifying the spatial distribution of cells or sub-cellular structures comprising (a) receiving image data comprising a plurality of biomarkers, N, wherein the data represents a spatial map of the biomarkers; (b) processing the data to obtain a set of coordinates, wherein each coordinate denotes the location of a cell or sub-cellular structure represented by a biomarker or combination of biomarkers; and (c) processing the set of coordinates into a two-dimensional symmetric (2N?1)×(2N?1) or 2N×2N matrix (D). Also provided is the use of this method for assigning subjects one or more clinical characteristics, the use of this method for forming and/or testing scientific hypotheses for one or more interventions, and apparatus comprising at least one processor configured to perform the method.
    Type: Application
    Filed: October 4, 2013
    Publication date: April 9, 2015
    Applicant: The University of Manchester
    Inventors: Richard John Byers, Christopher Rose
  • Patent number: 8999635
    Abstract: The present invention relates to the identification of loss-of-function mutations in the filaggrin gene and their use in diagnosing ichthyosis vulgaris and/or susceptibility to other diseases including atopic dermatitis (eczema), asthma, psoriasis and allergies (including food allergy).
    Type: Grant
    Filed: December 15, 2006
    Date of Patent: April 7, 2015
    Assignee: University Court of The University of Dundee
    Inventors: William Henry Irwin McLean, Frances Jane Dorothy Smith
  • Patent number: 9000050
    Abstract: Compounds of structure (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, R2 and A are as defined herein are disclosed. Such compounds have enhanced water solubility and have activity as SHIP1 modulators, and thus may be used to treat any of a variety of diseases, disorders or conditions that would benefit from SHIP1 modulation. Enantioselective methods for preparation of compounds of structure (I), compositions comprising a compound of structure (I) in combination with a pharmaceutically acceptable carrier or diluents and methods of SHIP1 modulation by administration of such compounds to an animal in need thereof are also disclosed.
    Type: Grant
    Filed: August 22, 2011
    Date of Patent: April 7, 2015
    Assignee: The University of British Columbia
    Inventors: Xiaoxia Wang, Labros George Meimetis, Matthew Bruce Nodwell, Raymond Andersen
  • Patent number: 9001320
    Abstract: A technique for forming a two-dimensional electronic spectrum of a sample includes illuminating a line within a portion of the sample with four laser pulses; where along the entire line the difference in the arrival times between two of the laser pulses varies as a function of the position and the difference in the arrival times between the other two pulses is constant along the entire line. A spectroscopic analysis may then be performed on the resulting pulsed output signal from the illuminated line to produce a single-shot two dimensional electronic spectroscopy.
    Type: Grant
    Filed: August 16, 2011
    Date of Patent: April 7, 2015
    Assignee: The University of Chicago
    Inventors: Elad Harel, Gregory S. Engel
  • Patent number: 8999024
    Abstract: An abrasive element comprises a body of crystalline abrasive material. The body has an array of cutting elements formed of crystalline abrasive material which projects from a surface of the body. The shape, size and form of the projections is controlled in the production process. The body may be a natural or synthetic crystal. The body may be a film formed by deposition. The body may be diamond or cubic boron nitride. The body may be monocrystalline or polycrystalline. The projections may be aligned along a crystallographic plane or planes.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: April 7, 2015
    Assignee: The University of Nottingham
    Inventors: Dragos Axinte, Paul Butler-Smith, Mark Daine
  • Patent number: 8999443
    Abstract: A method for fabricating a microarray of plural soft materials includes: vapor-depositing a first layer poly(para-xylylene) resin on a substrate, forming a first micro pattern in the poly(para-xylylene) resin; obtaining a substrate including a first microarray formed by pouring a first soft material solution, freeze-drying the first soft material to obtain a micro-arrayed substrate of the freeze-dried first soft material; vapor-depositing a second layer poly(para-xylylene) resin on the micro-arrayed substrate of the freeze-dried first soft material, forming a second micro pattern placed differently from the first micro pattern by penetrating the poly(para-xylylene) resin of the first and second layers, forming a second microarray on the substrate by pouring a second soft material solution; and forming a microarray of the first and second soft materials on the substrate by peeling off the poly(para-xylylene) resin of the first and second layers.
    Type: Grant
    Filed: March 27, 2012
    Date of Patent: April 7, 2015
    Assignees: NTT DOCOMO, INC., The University of Tokyo
    Inventors: Satoshi Hiyama, Kaori Kuribayashi, Hiroaki Onoe, Shoji Takeuchi
  • Patent number: 9000137
    Abstract: The present invention provides nucleic acid aptamers that bind to Plasmodium proteins lactate dehydrogenase and histidine-rich protein II, and uses thereof for the diagnosis of malaria. Aptamers against histidine-rich protein II may be used to detect the presence of Plasmodium species in general, whereas aptamers against lactate dehydrogenase can be used to specifically detect Plasmodium falciparum.
    Type: Grant
    Filed: February 8, 2013
    Date of Patent: April 7, 2015
    Assignee: The University of Hong Kong
    Inventors: Julian A Tanner, Yee Wai Cheung, Masayo Kotaka
  • Patent number: 9000432
    Abstract: A multilayered structure is provided. The multilayered structure may include a silicon substrate and a film of gadolinium oxide disposed on the silicon substrate. The top surface of the silicon substrate may have silicon orientated in the 100 direction (Si(100)) and the gadolinium oxide disposed thereon may have an orientation in the 100 direction (Gd2O3(100)).
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: April 7, 2015
    Assignee: The University of North Carolina at Charlotte
    Inventors: Raphael Tsu, Wattaka Sitapura, John Hudak
  • Patent number: 9000931
    Abstract: A noise processing apparatus measures a first potential difference signal, between a first electrode and a second electrode that is used as a reference electrode, and measures a second potential difference signal, between the second electrode and a third electrode that is arranged on the steering unit in the apparatus. The apparatus calculates the difference between the intensities of the first potential difference signal and the second potential difference signal calculated at the predetermined intervals. The apparatus corrects the first potential difference signal or the second potential difference signal by using the calculated difference such that the intensities of the first potential difference signal and the second potential difference signal are canceled out.
    Type: Grant
    Filed: May 30, 2012
    Date of Patent: April 7, 2015
    Assignees: Fujitsu Limited, The University of Tokyo
    Inventors: Hideki Tomimori, Ken Sasaki, Yasuhiko Nakano, Satoshi Sano, Yoshio Ishida
  • Patent number: 8999934
    Abstract: The disclosure relates to an endothelin receptor antagonist for use in the prevention or treatment of brain metastases in combination with a cytotoxic chemotherapy agent, radiotherapy or both. The endothelin receptor antagonist may for example be bosentan, macitentan or a mixture of bosentan and macitentan.
    Type: Grant
    Filed: August 9, 2010
    Date of Patent: April 7, 2015
    Assignee: Board of Regents, The University of Texas System
    Inventors: Isaiah Fidler, Sun-jin Kim
  • Patent number: 9000009
    Abstract: Methods for improving mitochondrial function, decreasing iron accumulation, and/or decreasing oxidative stress by exposing cells or treating a subject to compounds or compositions of the general formula (I) are described that are beneficial in treating, for example, diseases and conditions such as Friedreich's ataxia, normal aging, and various neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Furthermore, such compounds are useful as probes for identifying defects in mitochondrial metabolism, mitochondrial iron accumulation, cellular stress among other mitochondrial diseases and helping to identify compounds active in overcoming such defects.
    Type: Grant
    Filed: December 10, 2009
    Date of Patent: April 7, 2015
    Assignee: The Trustees Of The University Of Pennsylvania
    Inventors: Robert B. Wilson, Maria Grazia Cotticelli, Phillip A. Benedetti, Amos Smith, Jason E. Melvin, Donna M Huryn
  • Patent number: 8999052
    Abstract: Fine mesoporous silica particles are provided by which not only the functions of low reflectance (Low-n), low dielectric constant (Low-k) and low thermal conductivity but also improved strength of a molded article are achieved. The fine mesoporous silica particles are manufactured by a process including a surfactant composite fine silica particle preparation step and a mesoporous particle formation step. In the silica fine particle preparation step, a surfactant, water, an alkali and a hydrophobic part-containing additive including a hydrophobic part for increasing the volume of micelles are mixed with a silica source to thereby prepare surfactant composite fine silica particles. In the mesoporous particle formation step, the mixture is mixed with an acid and an organosilicon compound to thereby remove the surfactant and hydrophobic part-containing additive from the surfactant composite fine silica particles and provide the surface of each silica fine particle with an organic functional group.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: April 7, 2015
    Assignees: Panasonic Corporation, The University of Tokyo
    Inventors: Hiroki Yabe, Takeyuki Yamaki, Yasuto Hoshikawa, Tatsuya Okubo, Atsushi Shimojima